BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18680517)

  • 1. Bordetella pertussis filamentous hemagglutinin delivered by mucosal routes enhances immunoglobulin levels in serum and mucosal fluids.
    Poulain-Godefroy O; Vendeville C; Locht C; Riveau G
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):129-36. PubMed ID: 18680517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE; Lapé-Nixon M; Matud J
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.
    Renauld-Mongénie G; Mielcarek N; Cornette J; Schacht AM; Capron A; Riveau G; Locht C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7944-9. PubMed ID: 8755582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant activity of free Bordetella pertussis filamentous haemagglutinin delivered by mucosal routes.
    Poulain-Godefroy O; Menozzi FD; Alonso S; Vendeville C; Capron A; Locht C; Riveau G
    Scand J Immunol; 2003 Nov; 58(5):503-10. PubMed ID: 14629622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough].
    Chodorowska M
    Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related differences in patterns of increased Bordetella pertussis antibodies.
    Prince HE; Lieberman JM; Cherry JD
    Clin Vaccine Immunol; 2012 Apr; 19(4):545-50. PubMed ID: 22357646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of antibodies to Bordetella antigens in German adults.
    Saemann-Ischenko G; Tillmanns B; Kösters K; Riffelmann M; Wirsing von König CH
    Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):850-3. PubMed ID: 11837635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally.
    Poulain-Godefroy O; Mielcarek N; Ivanoff N; Remoué F; Schacht AM; Phillips N; Locht C; Capron A; Riveau G
    Infect Immun; 1998 Apr; 66(4):1764-7. PubMed ID: 9529111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
    Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
    J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.
    Berstad AKH; Holst J; Frøholm LO; Haugen IL; Wedege E; Oftung F; Haneberg B
    J Med Microbiol; 2000 Feb; 49(2):157-163. PubMed ID: 10670566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genital antibody responses in mice after intranasal infection with an attenuated candidate vector strain of Bordetella pertussis.
    Mielcarek N; Nordström I; Menozzi FD; Locht C; Holmgren J
    Infect Immun; 2000 Feb; 68(2):485-91. PubMed ID: 10639408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies produced against a fragment of filamentous haemagglutinin (FHA) of Bordetella pertussis are able to inhibit hemagglutination induced by the whole adhesin.
    Colombi D; Horton DS; Oliveira ML; Sakauchi MA; Ho PL
    FEMS Microbiol Lett; 2004 Nov; 240(1):41-7. PubMed ID: 15500977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories.
    Wong KH; Skelton SK
    J Clin Microbiol; 1989 Dec; 27(12):2805-10. PubMed ID: 2556434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
    Mielcarek N; Riveau G; Remoué F; Antoine R; Capron A; Locht C
    Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
    Torkashvand A; Bahrami F; Adib M; Ajdary S
    Microb Pathog; 2018 Jul; 120():155-160. PubMed ID: 29738814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. I. Antibody level for B pertussis antigens in children without respiratory tract infection symptoms].
    Chodorowska M
    Med Dosw Mikrobiol; 1999; 51(3-4):259-68. PubMed ID: 10803255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns.
    Heininger U; Riffelmann M; Leineweber B; Wirsing von Koenig CH
    Pediatr Infect Dis J; 2009 May; 28(5):443-5. PubMed ID: 19319020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.